Clinical trial
Phase 1 Trial of Na-ASP-2 Hookworm Vaccine in Previously Infected Brazilian…
NCT00473967 · Albert B. Sabin Vaccine Institute, Other · Terminated
Key facts
| NCT number | NCT00473967 |
|---|---|
| Title | Phase 1 Trial of Na-ASP-2 Hookworm Vaccine in Previously Infected Brazilian Adults |
| Official title | Double-blind, Randomized, Controlled Phase 1 Study of the Safety and Immunogenicity of Na-ASP-2 Hookworm Vaccine in Previously-Infected Brazilian Adults |
| Lead sponsor | Albert B. Sabin Vaccine Institute, Other |
| Collaborators | Oswaldo Cruz Foundation George Washington University London School of Hygiene and Tropical Medicine |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Hookworm Infection |
| Intervention type | Biological |
| Interventions | Na-ASP-2 Hookworm Vaccine |
| Enrollment | 9 |
| Start date | May 1, 2007 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2009 |
| First posted | May 16, 2007 |
| Last update posted | Jul 9, 2012 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: